Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer
Study Details
Study Description
Brief Summary
This research is designed to compare proximal gastrectomy anterior anastomosis with pyloroplasty with esophagogastric anastomosis for gastric cancer. Gastroesophageal reflux disease, postoperative quality of life, short term outcomes, and long term outcomes will be compared.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty (GAP) The reconstruction including esophagogastric anastomosis and pyloroplasty for patients who underwent proximal gastrectomy . The anastomosis locate in the anterior of gastric stump. |
Procedure: Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty
The location of the anastomosis in the anterior of the gastric stump. Pyloroplasty is added in the procedure
|
Active Comparator: Control The reconstruction including esophagogastric anastomosis and pyloroplasty for patients who underwent proximal gastrectomy . The anastomosis locate in the posterior or side of gastric stump. |
Procedure: Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty
The location of the anastomosis in the anterior of the gastric stump. Pyloroplasty is added in the procedure
|
Outcome Measures
Primary Outcome Measures
- Gastroesophagus reflux disease apprised by ph monitoring [6 months]
Ph monitoring by wireless or wire device
- Gastroesophagus reflux disease apprised by questionnaire [6 months]
PGSAS-45 questionnaire is adopted.
Secondary Outcome Measures
- Surgical complications of proximal gastrectomy for gastric cancer [1 year]
Surgical complications include anastomotic leakage, anastomotic stricture, postoperative bleeding, pleural effusion, et al.
- Long-term outcome [5 years]
Total survival time after proximal gastrectomy for gastric cancer
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.
-
Eastern Cooperative Oncology Group performance status of 0 or 1.
-
Adequate organ function.
Exclusion Criteria:
-
Patients had distant metastasis.
-
oesophageal invasion of more than 3 cm.
-
Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.
-
Previous chemotherapy or radiation therapy for any other malignancies.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Yunhong Tian | Nanchong | Sichuan | China | 637000 |
Sponsors and Collaborators
- Nanchong Central Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 20220720